FDA Investigator: Kalavati C. Suvarna
- Kalavati C. Suvarna first started conducting FDA inspections in 2009, with the last inspection in 2014. Over that time, Kalavati C. Suvarna has conducted 21 inspections at 19 companies across 20 sites.
Get Kalavati Suvarna's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Merckle Biotec GmbH, Ulm | 2013
Out-of-stock
Kalavati C. Suvarna
Human Drug Form 483
FDA 483 Richter Helm Biologics GmbH a, Hamburg | 2013
Out-of-stock
Kalavati C. Suvarna
Human Drug Form 483
FDA 483 Richter Helm Biologics, Bovenau | 2013
Out-of-stock
Kalavati C. Suvarna
Human Drug Form 483
FDA 483 Richter Helm Biologics GmbH and Co KG, Bovenau | 2013
Out-of-stock
Kalavati C. Suvarna
Human Drug Form 483
FDA 483 Genzyme Corporation, Framingham | 2011
Out-of-stock
Kalavati C. Suvarna
Human Drug Form 483
FDA 483 Regeneron Pharmaceuticals Inc, Rensselaer | 2011
Out-of-stock
Kalavati C. Suvarna
Human Drug Form 483
FDA 483 Human Genome Sciences Inc, Rockville | 2010
Out-of-stock
Kalavati C. Suvarna
Human Drug Form 483
FDA 483 Janssen Biologics (Ireland), Ringaskiddy | 2010
Out-of-stock
Kalavati C. Suvarna
Human Drug Form 483
FDA 483 Roche Singapore Technical Operations Pte. Ltd., Singapore | 2010
Out-of-stock
Kalavati C. Suvarna
Human Drug Form 483
FDA 483 Shire Human Genetic Therapies Inc, Lexington | 2009
Out-of-stock
Kalavati C. Suvarna
Human Drug Form 483
FDA 483 Human Genome Sciences Inc, Rockville | 2009
Out-of-stock
Kalavati C. Suvarna
Human Drug Form 483